Skip to main content
Clinical Trials/CTRI/2024/03/064926
CTRI/2024/03/064926Not yet recruitingPhase 3 4

A Clinical And Experimental Study Of Yoni Dhawan And Yoni Puran With Indigenous Drugs In Management Of SHWETA PRADAR(Abnormal Vaginal Discharge)

Dr Vijay Chaudhary Principal1 site in 1 country90 target enrollmentStarted: April 15, 2024Last updated:

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
Overall improvement which will be shown by the patients in P/S P/V examination & sign and symptoms.

Study Overview

Brief Summary

Research report will be soon published after the completion of trial 90 patients fulfilling the Inclusion and Exclusion criterias will be randomly selected from the OPD and IPD of department of Prasuti Tantra evum Stree Roga, RGGPG Ayurvedic College and Hospital Paprola Distt Kangra HP.

patient will be divided into three groups of  30  each 1. Yoni Dhawan with kwath of Anubhoota Yog  2. Yoni Puran with Kalka of Anubhoota Yoga 3. Vaginal suppository with clindamycin 100 mg & clotrimazole with 100 mg.

Duration of trial - 7 days for 2 consecutive cycles after clearance of menstruation.

Follow up - 1st follow up - after 10 days of 1st drug administration.

2nd follow up - after clearance of menstruation at next cycle (2nd menstrual cycle)

3rd follow up - after 10 days of 2nd drug administration.

Drug free period- after the clearance of 3rd menstrual cycle.

Result will be assessed on the basis of subjective and objective assessment  criterias.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 40.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Patient willing, giving consent and able to participate in the trial.
  • patient between age group of 20-40 years.
  • clinically diagnosed patients which fell under symptomatic criteria of Shweta Pradar.
  • Married female patients.

Exclusion Criteria

  • Unmarried Women
  • Pregnancy
  • Age- less than 20 years & more than 40 years
  • Patient having Venereal diseases
  • genital malignancies
  • Diabetic and severely anemic 7.

Outcomes

Primary Outcomes

Overall improvement which will be shown by the patients in P/S P/V examination & sign and symptoms.

Time Frame: once a day for 7 days for 2 consecutive cycles after clearance of menstruation

Secondary Outcomes

  • Overall improvement which will be shown by the patients in P/S P/V examination & sign and symptoms.(once a day for 7 days for 2 consecutive cycles after clearance of menstruation)

Investigators

Sponsor
Dr Vijay Chaudhary Principal
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Prof Seema Shukla

Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola Distt Kangra HP

Study Sites (1)

Loading locations...

Similar Trials